Three new synthetic progestins in the treatment of endometriosis.

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (11)

• Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis 2001
• Progestins for symptomatic endometriosis: a critical analysis of the evidence 1997
• Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur®), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome 1997
• Medical management of endometriosis 1993
• Gestogens and anti-gestogens as treatment of endometriosis 1991
• Hormonal and Surgical Management of Pelvic Endometriosis 1982
• The Surgical Treatment of Endometriosis 1978
• Antigonadotropin (danazol) in the treatment of endometriosis 1978
• Management of Endometriosis in the Infertile Patient 1975
• The prevention, inhibition, palliation, and treatment of endometriosis 1975
• Colorectal endometriosis 1973

Source provenance

europepmc

last seen: 2026-08-08T06:08:32.324769+00:00

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

pubmed

last seen: 2026-05-14T05:59:23.748286+00:00